NCT04203862 - A Study of NPC-22 in Healthy Adult Males | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 19, 2019

Primary Completion Date

February 4, 2020

Study Completion Date

February 4, 2020

Conditions

Healthy Adult Subjects

Interventions

DRUG

NPC-22

Single administration of low dose NPC-22

DRUG

NPC-22

Single administration of low/middle dose NPC-22

DRUG

NPC-22

Single administration of middle dose NPC-22

DRUG

NPC-22

Single administration of middle/high dose NPC-22

DRUG

NPC-22

Single administration of high dose NPC-22

DRUG

NPC-22 Placebo

Single administration of NPC-22 Placebo

Trial Locations (1)

Medical Corporation Shinanokai Shinanozaka Clinic, Shinjuku